Nonoperating Income (Expense) in USD of GLYCOMIMETICS INC from Q1 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Glycomimetics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2013 to 2024.
  • Glycomimetics Inc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $1.41M, a 131% increase year-over-year.
  • Glycomimetics Inc annual Nonoperating Income (Expense) for 2024 was $2.16M, a 9.08% decline from 2023.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)

GLYCOMIMETICS INC Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.41M +$798K +131% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q3 2023 $611K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q1 2014 $4.77K -$960K -99.5% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-09
Q1 2013 $965K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09

GLYCOMIMETICS INC Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.16M -$216K -9.08% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-13
2023 $2.38M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.